Medical Services International to Begin Shipping VScan HIV Test Kits Into Europe
Posted on: Thursday, 6 July 2006, 15:00 CDT
EDMONTON, Alberta, July 6 /PRNewswire-FirstCall/ -- Medical Services International Inc. wishes to announce that it will begin shipping its VScan HIV test kits into several European countries who are now doing their own testing rather than wait for Medical Services to get CE approval. Preliminary testing by departments of health in several European countries has resulted in test data from the VScan HIV test kit that exceeded expectations. Consequently, rather than wait for the Company to obtain a CE mark for its HIV test kit, these countries have decided to complete the necessary testing for regulatory approval themselves through their departments of health. Upon successful completion of the testing of the VScan HIV test kits by the departments of health, Medical Services will receive clearance to begin selling its VScan HIV test kit in that country.
It has become apparent that there is a significant demand for a reliable, accurate HIV rapid test kit that uses whole blood and does not require medical facilities. The fact that the VScan detects the IgM antigen within 2 to 11 days of infection when other kits do not, makes it the most sensitive and accurate test kit available.
Market studies show that the demand for an HIV test kit like the VScan HIV test kit will be in excess of 2 to 3 million kits per year.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ .
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,+1-780-430-6363
Web site: http://www.medicalservicesintl.com/http://www.minerva-biotech.com/
Source: PRNewswire-FirstCall
Related Articles
- Medical Services Gets Significant Interest in Its Dual VScan Test Kit
- Medical Services International Signs Agreement With US Biotech Firm to Begin Approval Process in the United States For The VScan TB and Hepatitis C Test Kits
- Medical Services Completes Further Testing of Its VScan HIV Test Kit With Excellent Results
- Medical Services International Begins Shipping VScan TB Test Kits to South Africa
- Medical Services VScan HIV Test Kit Used During LIVE Test on Television
- Medical Services International to Supply VScan Test Kits for Private Testing
- Medical Services Receives Order for 1.0 Million VScan Test Kits From the Middle East
- Medical Services Receives Regulatory Approval for Its VScan Tuberculosis (TB) Rapid Test Kit
- Medical Services to Supply Law Enforcement Agencies With HIV Test Kits
 |
 |
User Comments (0)
RSS Feeds